Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay Huan ChenDa TranYumei Ye Original Article 25 April 2020 Pages: 443 - 461
Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway Xing ChenXingzuan JiangShiming Liu Routine Article 11 May 2020 Pages: 463 - 473
Single-Strand DNA-Like Oligonucleotide Aptamer Against Proprotein Convertase Subtilisin/Kexin 9 Using CE-SELEX: PCSK9 Targeting Selection Roohollah SattariAbbasali PalizbanHossein Khanahmad Original Article 15 May 2020 Pages: 475 - 485
Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats Aysegul DurakCeylan V. BitirimBelma Turan Original Article 06 May 2020 Pages: 487 - 501
Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction Yajun GuiJingyuan ChenDanyan Xu Review Article 11 May 2020 Pages: 503 - 513
Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study Gisle LangsletG. Kees HovinghMichel Farnier Original Article Open access 04 May 2020 Pages: 515 - 523
Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study Wenhao JiaYan LiQian Lin Original Article Open access 23 March 2020 Pages: 525 - 534
Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance Kazuhiro ShindoHiroki FukudaMasafumi Kitakaze Original Article 12 May 2020 Pages: 535 - 545
Inpatient Initiation of Oral Treprostinil in an Academic Medical System Benjamin HohlfelderAdriano R. TonelliSeth R. Bauer Original Article 19 May 2020 Pages: 547 - 553
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients Andreas SchäferUlrike FlierlJohann Bauersachs Review Article Open access 29 April 2020 Pages: 555 - 568
Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies Xin LiuZi-Xuan XuWen-Gen Zhu Review Article 15 April 2020 Pages: 569 - 578
Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare Michael GilletteAddison TaylorHani Jneid Editorial 21 April 2020 Pages: 579 - 584
A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization Jamie S. Y. HoPaul A. TambyahChing-Hui Sia Letter to the Editor 08 May 2020 Pages: 585 - 587
Letter to the Editor: Increased Circulating Angiopoietin-like Protein 8 Levels Are Associated with Thoracic Aortic Dissection and Higher Inflammatory Conditions Xiaoming Jia Letter to the Editor 04 May 2020 Pages: 589 - 589
